DP018 | HYPOMETHYLATING AGENTS ALONE STILL HAVE A ROLE IN ACUTE MYELOID LEUKEMIA TREATMENT: RESULTS OF A RETROSPECTIVE REAL-LIFE STUDY ON 132 PATIENTS.

Decitabine (DEC) and Azacitidine (AZA) alone or in combination with Venetoclax (VEN) represent the gold standard treatment for unfit patients (pts) with acute myeloid leukemia (AML). As these two strategies differ in terms of efficacy (greater with HMAs-VEN combination) and tolerability (better wit...

Full description

Bibliographic Details

Published in:	Haematologica
Main Authors:	R. Palmieri, F. Pilo, M. Pettinau, G. Paterno, F. Mallegni, E. Meddi, F. Moretti, I. Cerroni, M.I. Del Principe, L. Maurillo, G. Caocci, A. Venditti
Format:	Article
Language:	English
Published:	Ferrata Storti Foundation 2025-09-01
Online Access:	https://haematologica.org/article/view/12782